GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Ранг среди акций
#3635
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Цена акции
$27.54
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$4.67B
Изменение (1 день)
-2.73%
Изменение (1 год)
-12.13%
Страна
IN
Торговля GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Категория
Healthcare
История дивидендной доходности для GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Дивидендная доходность (TTM) компании GlaxoSmithKline Pharmaceuticals Limited (тикер: GLAXO) на 2024-03-31 составляет: 1.61%
Средняя дивидендная доходность за последние 5 лет: 2.91%
Средняя дивидендная доходность за последние 5 лет: 2.91%
История дивидендной доходности компании GlaxoSmithKline Pharmaceuticals Limited (GLAXO) с 2004 по 2026
Дивидендная доходность на конец каждого года (TTM)
| Год | Дивидендная доходность | Изменить |
|---|---|---|
| 2026 (TTM) | 2.28% | 44.30% |
| 2025 | 1.58% | -1.86% |
| 2024 | 1.61% | -76.32% |
| 2023 | 6.80% | 279.89% |
| 2022 | 1.79% | -35.38% |
| 2021 | 2.77% | 44.27% |
| 2020 | 1.92% | 42.22% |
| 2019 | 1.35% | -5.59% |
| 2018 | 1.43% | -21.43% |
| 2017 | 1.82% | 10.98% |
| 2016 | 1.64% | 40.17% |
| 2015 | 1.17% | -29.52% |
| 2013 | 1.66% | -19.42% |
| 2012 | 2.06% | 0.49% |
| 2011 | 2.05% | 60.16% |
| 2010 | 1.28% | -48.18% |
| 2009 | 2.47% | -20.58% |
| 2008 | 3.11% | 3.67% |
| 2007 | 3.00% | 25.00% |
| 2006 | 2.40% | 10.60% |
| 2005 | 2.17% | 65.65% |
| 2004 | 1.31% | 0.00% |
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
| Компания | Дивидендная доходность | Страна |
|---|---|---|
| 0.55% |
US
|
|
| 2.08% |
US
|
|
| 2.44% |
US
|
|
| 2.31% |
US
|
|
| 2.69% |
CH
|
